Please login to the form below

Not currently logged in
Email:
Password:

personalised medicine

This page shows the latest personalised medicine news and features for those working in and with pharma, biotech and healthcare.

NICE unveils long-awaited review of methodologies

NICE unveils long-awaited review of methodologies

He added: “NICE is undertaking this review at a time of unprecedented change in the healthcare system, where developments such as personalised medicine, digitalisation of health, and use of cell and

Latest news

  • As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority As Europe goes to polls, pharma seeks to keep healthcare, R&D a priority

    But if we truly pool all our knowledge and resources together, we can pursue ambitious goals so that, by combining prevention, early diagnosis and screening with personalised medicine, we could dramatically

  • Lynparza could soon add first line ovarian use in Europe Lynparza could soon add first line ovarian use in Europe

    As with other ‘personalised medicine’ drugs, the company’s commercial division is aiming to maximise uptake by broadening access to companion diagnostics which can identify BRCA mutations in patients across these

  • J&J’s targeted bladder cancer treatment gets US approval J&J’s targeted bladder cancer treatment gets US approval

    We’re in an era of more personalised or precision medicine, and the ability to target cancer treatment to a patient’s specific genetic mutation or biomarker is becoming the standard, ... Despite the first-to-market personalised medicine claim for

  • Going digital Going digital

    A new era, Medicine 2.0, is dawning too, where healthcare starts to harness the latest technology and the scope for personalised treatment grows. ... Personalised medicine means giving doctors and patients the abilities to adjust and calibrate treatment

  • Big opportunities in big data, but EMA and industry just getting started Big opportunities in big data, but EMA and industry just getting started

    The taskforce's visual representation of the Big Data roadmap. Respondents from large pharma tended to highlight personalised medicine, understanding current clinical care and informing clinical trial design as areas where

More from news
Approximately 10 fully matching, plus 105 partially matching documents found.

Latest Intelligence

  • Changing direction: adapting to a rapidly-evolving environment Changing direction: adapting to a rapidly-evolving environment

    When you marry this up with advances such as personalised medicine and nanotechnology, it’s easy to see how technology could finally help us deliver on the promise that prevention is ... on its own. Fulfilling the promise of predictive technology and

  • The dawn of a new era in medical education The dawn of a new era in medical education

    By Annlouise Pendse. We are living in a pivotal moment in medical history. The first wave of personalised medicines is now available and is changing the way diseases are identified and ... delivering often complex personalised medicine.

  • AI is transforming pharma R&D – now it can transform pharma marketing AI is transforming pharma R&D – now it can transform pharma marketing

    As we move towards a future of personalised medicine, AI could assist in the identification of suitable patients for each therapy, helping HCPs construct tailored medicine regimes for patients. ... Conclusion. AI is evolving rapidly. The early adopters

  • Genomics integration: can the NHS rise to the challenge? Genomics integration: can the NHS rise to the challenge?

    With its potential in drug development, personalised medicine and transforming patient outcomes, the study of the human genome could address some of life sciences’ biggest challenges, including rising healthcare costs. ... We can then make sure

  • Cell and gene therapy Cell and gene therapy

    While manufacturing any medicine is a complex process, traditional therapies are manufactured through a linear process, from mass production to packaging and delivery to patients. ... For traditional biopharmaceutical products one batch equals many doses,

More from intelligence
Approximately 4 fully matching, plus 29 partially matching documents found.

Latest appointments

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”.

  • Stephen Eck joins Aravive Biologics Stephen Eck joins Aravive Biologics

    chairman of the board of directors of the Personalised Medicine Coalition.

  • FlowMetric Diagnostics names president FlowMetric Diagnostics names president

    It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised medicine and better meet the needs of physicians, healthcare workers and

  • GlobalData makes Americas appointment GlobalData makes Americas appointment

    Dr Bonnie Bain, global head of healthcare at GlobalData, adds: “Sean is widely recognised as an expert and thought leader in personalised and translational medicine, and it's great to welcome

  • Roche appoints new oncology research head Roche appoints new oncology research head

    Personalised cancer has been his forte, however, and he has served as director of personalised cancer medicine at Vanderbilt. ... I was particularly attracted to Roche as one of the pioneers and front-runners in personalised medicine, as the world's top

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • The changing face of pharma in the precision era

    Precision medicine equates understanding the patient’s molecular makeup and using this information and other clinical data to find targeted treatments. ... We are on the brink of a new way of practising medicine and pharmaceutical companies have the

  • Precision paediatrics: Treating patients with CAR-T

    This includes working with an expert team at the Great Ormond Street Institute of Child Health to help embed precision medicine throughout the organisation and ensuring there is an integrated and ... There is clear intent at NHS England that personalised

  • Making a difference with patient support

    Empowering the patient. Providing a stepping-stone to personalised medicine. Reassuring HCPs that the treatment is a both viable option for the patient and that it is adequately supported.

  • Battling breast cancer with precision medicine (Part 1)

    Laura Holmes Haddad is a breast cancer survivor. She made the incredibly brave decision to participate in a PARP inhibitor precision medicine trial. ... Here, the author and precision medicine advocate tells her story and explains what industry needs to

  • Trends in the Pharma Industry – A Lucid Thirsty Thursday Session

    Discussions were sparked around the changing way the world communicates and how information is consumed; how personalised medicine will impact the industry and where pharma sits in the world of big

More from PMHub
Approximately 4 fully matching, plus 23 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Nobull Communications

Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics